| 000 | 01864 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514204430.0 | ||
| 264 | 0 | _c20050302 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a1021-7401 | ||
| 024 | 7 |
_a10.1159/000080151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFelszeghy, Klára | |
| 245 | 0 | 0 |
_aDexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. _h[electronic resource] |
| 260 |
_bNeuroimmunomodulation _c2004 |
||
| 300 |
_a404-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aBrain Infarction _ximmunology |
| 650 | 0 | 4 |
_aCarotid Artery Injuries _xpathology |
| 650 | 0 | 4 | _aChemokine CXCL12 |
| 650 | 0 | 4 |
_aChemokines, CXC _ximmunology |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
| 650 | 0 | 4 |
_aGliosis _xpathology |
| 650 | 0 | 4 |
_aHypoxia-Ischemia, Brain _xdrug therapy |
| 650 | 0 | 4 | _aLigation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aReceptors, CXCR4 |
| 650 | 0 | 4 |
_aReceptors, Chemokine _xdrug effects |
| 650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aBanisadr, Ghazal | |
| 700 | 1 | _aRostène, William | |
| 700 | 1 | _aNyakas, Csaba | |
| 700 | 1 | _aHaour, France | |
| 773 | 0 |
_tNeuroimmunomodulation _gvol. 11 _gno. 6 _gp. 404-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000080151 _zAvailable from publisher's website |
| 999 |
_c15159056 _d15159056 |
||